Instalab
logoInstalab

Streptococcus pneumoniae

Vaginal Swab Test
Investigate an uncommon possible cause of persistent vaginal irritation, with a result that needs clinical context.
4.8 (2,585 reviews)
Tested by US Biotek Laboratories
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped directly to you
Get results
Explained with clear next steps, no medical jargon

Should you take a Streptococcus pneumoniae test?

This test is most useful if any of these apply to you.

Dealing With Persistent Discharge or Irritation
May add information after common causes have been checked; a positive result alone doesn't identify the cause.
Still Symptomatic After Treatment
A targeted culture may help investigate less common bacteria when treatment hasn't worked.
Having Persistent Symptoms After Menopause
Symptoms can come from infection or hormone-related changes; this result may contribute to a broader assessment.

About Streptococcus pneumoniae

Streptococcus pneumoniae usually lives in the nose and throat, sometimes without causing illness. It can cause pneumonia, bloodstream infection, and meningitis, but those conditions require evidence from the affected site. Finding it on a vaginal swab raises a separate question about its significance in the vagina. CDC clinical overview

Vaginal pneumococcus is uncommon. Genital and pelvic infections caused by it are rare but documented in case reports. Using a quantitative vaginal result to diagnose the cause of irritation or guide preventive screening is a different matter, and that remains unproven. The available vaginal studies have not established a numerical cutoff separating carriage from infection.

What the Vaginal Studies Found

A 1995 study reviewed women whose vaginal cultures had already shown pure, heavy growth of one of several potentially harmful bacteria. This was a selected group, not a survey of all women having swabs. Pneumococcus appeared associated with vulvovaginitis, but there were too few pneumococcal cases for statistical confirmation. The study supports considering it as a possible cause; it does not establish that heavy growth proves infection. Original study

A ten-year Netherlands review examined vaginal cultures from more than 11,000 people with symptoms and negative sexually transmitted infection tests. Pneumococcus was grouped with Haemophilus influenzae, beta-haemolytic streptococci, and Staphylococcus aureus. Together, these organisms appeared in 5.6% of cultures. That percentage is not the prevalence of vaginal pneumococcus. The combined group was more frequent in children and postmenopausal women, which does not establish that pneumococcus itself is most common after menopause. Original study

After menopause, falling estrogen can itself cause dryness, burning, irritation, and discharge. An unusual bacterial finding can coexist with these changes, so attributing symptoms to the organism requires an examination and consideration of other causes. ACOG guidance

Local Symptoms and Less Common Complications

Vulvovaginitis is inflammation of the vulva and vagina. Discharge, itching, burning, and soreness can occur with several infections and with noninfectious irritation. Symptoms alone do not identify the organism responsible. CDC guidance

Pneumococcal pelvic infection is rare but well documented. Case reports and a small case series describe pelvic inflammatory disease, abscess, and peritonitis, including in previously healthy women and in women with positive vaginal cultures. Transmission from a colonized mother to a newborn has also been documented. These reports establish that serious complications are possible, but they do not estimate your risk from an isolated positive swab. Pelvic infection report, maternal-to-newborn transmission report

Reading Your Number

This vaginal-swab result is reported in x10^5 CFU/ml, or multiples of 100,000 colony-forming units per milliliter. In a culture, a colony-forming unit represents a living bacterium or cluster of bacteria capable of producing a colony. It is not necessarily one individual bacterial cell.

The catalog does not specify the laboratory method. The unit alone therefore does not establish whether the reported amount is a direct culture count or an estimate from another technique. The vaginal studies discussed here used cultures, and their descriptions of pure or heavy growth cannot be converted into numerical thresholds for this assay.

Interpretation depends on the organism's identification, symptoms, examination findings, and other results from the sample. There is no validated numerical target for optimizing vaginal pneumococcus.

When Results Can Be Misleading

  • Carriage versus infection: finding the organism establishes its presence in the sample, but does not by itself show that it caused your symptoms.
  • Unspecified method: some DNA assays can detect dead bacteria or mistake related streptococci for pneumococcus. These limitations have been studied mainly in other specimen types; they do not establish the performance of this vaginal assay. Assay comparison study
  • Recent antibiotics: treatment can affect bacterial recovery and the relationship between culture and DNA detection. Pneumococcal studies in other specimen types document this problem, but the size and duration of the effect on this vaginal result are unknown. Assay comparison study
  • Collection: sampling the vaginal wall and avoiding contact with hands or surrounding surfaces helps prevent collection errors. The supplied kit's instructions determine the correct procedure for this test. Example of vaginal-swab collection instructions

Group B Strep Is a Separate Species

Group B strep is Streptococcus agalactiae. Prenatal screening targets that organism because it can pass to a baby during birth. Studies of group B strep screening, treatment, or pregnancy outcomes cannot establish what a vaginal pneumococcal result means. CDC screening guidance

What Repeated Results Can Show

Repeated detection can document persistence, but persistence alone does not prove that the organism is causing symptoms. The vaginal studies cited here have not established a change in this number that predicts recovery, recurrence, or future illness.

What Moves This Biomarker

Evidence-backed interventions that affect your Streptococcus pneumoniae level

↓ Decrease
Antibiotics selected for confirmed pneumococcal genital infection
An antibiotic active against the strain can strongly suppress viable pneumococci when they are causing infection. Genital-infection case reports describe recovery, sometimes with drainage or device removal. These reports do not quantify the change on this vaginal assay or establish a benefit from treating an incidental positive swab. [Clinical report](https://doi.org/10.1093/ofid/ofw257)
MedicationStrong Evidence

Frequently Asked Questions

Panels containing Streptococcus pneumoniae

Streptococcus pneumoniae is included in these pre-built panels.

References

15 studies
  1. M. Bruins, Claudy Oliveira Dos Santos, R. Damoiseaux, G. RuijsEuropean Journal of Clinical Microbiology & Infectious Diseases2021
  2. Parham Sendi, Eva Maria Moser Schaub, Konstantinos Nirgianakis, Lucy J. Hathaway, Pascal Bittel, David Goldblatt, Sven StreitOpen Forum Infectious Diseases2017
  3. L. Clifford Mcdonald, Kris Bryant, James SnyderJournal of Clinical Microbiology2003
  4. Maria Da Gloria S. Carvalho, Maria Lucia Tondella, Karen Mccaustland, Luciana Weidlich, Lesley Mcgee, Leonard W. Mayer, Arnold Steigerwalt, Melissa Whaley, Richard R. Facklam, Barry Fields, George Carlone, Edwin W. Ades, Ron Dagan, Jacquelyn S. SampsonJournal of Clinical Microbiology2007